Health News (Reuters)

Other factors may explain preterm births associated with IVF

(Reuters Health) - Women are more likely to have preemies when they use reproductive technologies like in vitro fertilization (IVF), but a new study comparing outcomes for these babies to siblings conceived naturally suggests that other factors may be the cause of these early arrivals.

Kidney function worsens as people get more obese

(Reuters Health) - With or without existing kidney disease, kidney function is more likely to decline over time the more severely obese a person is, a large study suggests.

FDA approves Mylan's generic of Advair asthma treatment

The U.S. Food and Drug Administration (FDA) approved Mylan NV's generic version of GlaxoSmithKline-developed blockbuster asthma treatment Advair, driving shares of Mylan 7 percent higher on Wednesday.

U.S. lawmakers request info from insulin makers on rising prices

Two powerful U.S. lawmakers sent letters to the three leading insulin manufacturers on Wednesday requesting information on why its cost has skyrocketed in recent years and how much the companies profit from the life-sustaining diabetes treatment.

As we age, sexual activity still important for wellbeing

(Reuters Health) - - The benefits of a healthy sex life aren't limited to young adults, according to a UK study that found intimacy and sexual activity are important for older adults' well-being, too.

Roche, AC Immune drop Alzheimer drug trials after setback

Roche Holding and partner AC Immune SA called a halt to two late-stage clinical trials of their crenezumab drug for early Alzheimer's, the latest in a string of failures to find a treatment for the progressive brain disease.

Roche drops Alzheimer drug trials after setback

Roche Holding will halt two late-stage clinical trials of its crenezumab drug for early Alzheimer's disease after an interim analysis indicated it was unlikely to hit its primary goal, the Swiss drugmaker said on Wednesday.

Pages